Dr Lawrence Fong | CureTalks
Lawrence Fong, MD, is the Efim Guzik Distinguished Professor in Cancer Biology and leads the Cancer Immunotherapy Program at UCSF. He also co-directs the Parker Institute for Cancer Immunotherapy at UCSF and co-leads the Cancer Immunology Program in the Helen Diller Family Comprehensive Cancer Center. He is a physician-scientist in the Department of Medicine, Division of Hematology/Oncology directing both a translational research program and a research lab. He has focused on cancer immunotherapy for over 20 years and has been involved in both pre-clinical and clinical studies of FDA-approved immunotherapies including sipuleucel-T and immune checkpoint inhibitors. Dr. Fong's research focuses on understanding the mechanisms that underlie clinical response and resistance to immunotherapies. The Cancer Immunotherapy Program that he directs performs early phase and high risk clinical trials across different disease indications. This program also includes a translational laboratory that performs mechanistic studies on samples derived from patients undergoing treatment.
Beyond CAR-T: Re-engineering Cells into Life-saving Therapies
Our cells have the innate ability to protect us. The idea of using cells as medicine emerged with bone marrow transplants, and then…
Conquering Cancer from Within. Immunotherapy, the new Hope.
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Several types of immunotherapy are used to treat cancer.…